By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chiasma Inc. 

10 Hartom Street, 2nd Floor
P.O. Box 45182
Jerusalem    91450  Israel
Phone: 972-2-571-5885 Fax: 972-2-571-5886


Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPEĀ®) technology platform, Chiasma seeks to select, develop and ultimately commercialize oral medications that are currently only available as injections.




Founders: Guy Yachin, Muli Ben Sasson

CEO: Mark Leuctenberger

CFO: Mark Fitzpatrick


Please click here for Chiasma job opportunitites.


Please click here for clinical trial information.

Key Statistics

Ownership: Private

Web Site: Chiasma

Company News
Chiasma Appoints Roni Mamluk, Ph.D. To Board Of Directors 6/19/2017 7:46:16 AM
Chiasma Enforces Job-Cutting Scheme, Axing a Further 44% of Workforce 8/16/2016 7:17:25 AM
Struggling Chiasma Chops 33% of Workforce After FDA Drug Rejection 6/15/2016 6:33:34 AM
Chiasma Chief Says Firm May Challenge FDA Over Rare-Disease Drug Rejection 5/12/2016 6:30:36 AM
Chiasma Crashes on FDA Drug Rejection of Mycapssa 4/18/2016 7:31:34 AM
Chiasma Reviews 2015 Accomplishments And Outlines Core Objectives For 2016 1/8/2016 7:57:33 AM
Chiasma Announces Addition Of James R. Tobin And John F. Thero To Board Of Directors 11/30/2015 7:33:45 AM
Chiasma Reports Third Quarter 2015 Financial Results And Recent Business Highlights 11/13/2015 8:04:48 AM
Chiasma To Present At Upcoming Investor Conferences 11/11/2015 10:16:47 AM
Chiasma Supports Acromegaly Awareness With Launch Of New Online Resource For Patients And Caregivers 10/30/2015 7:22:48 AM